Ctla-4 blockade confers lymphocyte resistance to regulatory T-cells in advanced melanoma: surrogate marker of efficacy of tremelimumab?

Source:http://linkedlifedata.com/resource/pubmed/id/18698043

Clin. Cancer Res. 2008 Aug 15 14 16 5242-9

Download in:

View as

General Info

PMID
18698043